Organization: Health Canada
Year: 2024
Month: February
Request Number: A-2023-001029
Request Summary: All correspondence in respect of the liraglutide submission which was removed from the Generic Submissions Under Review (GSUR) List some time between March 15, 2022 and December 13, 2022 between Health Canada and the company (sponsor) who submitted the Abbreviated New Drug Submission (ANDS).
Disposition: Disclosed in part
Number of pages: 18